Peng; Hairuo
Patent Applications and Registrations
Patent applications and USPTO patent grants for Peng; Hairuo.The latest application filed is for "atx modulating agents".
- Peng; Hairuo - Cambridge MA
- Peng; Hairuo - Needham MA
- Peng; Hairuo - Chestnut Hill MA
| Patent | Date |
|---|---|
| ATX modulating agents Grant 10,144,732 - Kumaravel , et al. De | 2018-12-04 |
| Sepiapterin reductase inhibitors Grant 9,963,462 - Tebbe , et al. May 8, 2 | 2018-05-08 |
| Compounds that are S1P modulating agents and/or ATX modulating agents Grant 9,944,666 - Guckian , et al. April 17, 2 | 2018-04-17 |
| Substituted pyrimidines for inhibiting Raf kinase activity Grant 9,920,048 - Chen , et al. March 20, 2 | 2018-03-20 |
| S1P and/or ATX modulating agents Grant 9,850,206 - Peng , et al. December 26, 2 | 2017-12-26 |
| S1P and/or ATX modulating agents Grant 9,771,326 - Peng , et al. September 26, 2 | 2017-09-26 |
| S1P modulating agents Grant 9,765,016 - Guckian , et al. September 19, 2 | 2017-09-19 |
| Atx Modulating Agents App 20170197960 - Kumaravel; Gnanasambandam ; et al. | 2017-07-13 |
| Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20170174710 - Guckian; Kevin M. ; et al. | 2017-06-22 |
| Atx Modulating Agents App 20170158687 - Guckian; Kevin M. ; et al. | 2017-06-08 |
| Compounds Useful as Raf Kinase Inhibitors App 20170158686 - CHEN; Weirong ; et al. | 2017-06-08 |
| Sepiapterin Reductase Inhibitors App 20170096435 - Tebbe; Mark Joseph ; et al. | 2017-04-06 |
| Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitors Grant 9,556,177 - Chen , et al. January 31, 2 | 2017-01-31 |
| Compounds that are S1P modulating agents and/or ATX modulating agents Grant 9,550,798 - Guckian , et al. January 24, 2 | 2017-01-24 |
| ATX modulating agents Grant 9,522,889 - Guckian , et al. December 20, 2 | 2016-12-20 |
| S1p And/or Atx Modulating Agents App 20160039825 - Peng; Hairuo ; et al. | 2016-02-11 |
| S1p Modulating Agents App 20150361029 - Guckian; Kevin ; et al. | 2015-12-17 |
| S1p And/or Atx Modulating Agents App 20150299123 - Peng; Hairuo ; et al. | 2015-10-22 |
| S1p And/or Atx Modulating Agents App 20150274663 - Peng; Hairuo ; et al. | 2015-10-01 |
| Atx Modulating Agents App 20150210647 - Guckian; Kevin ; et al. | 2015-07-30 |
| Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents App 20150203515 - Guckian; Kevin ; et al. | 2015-07-23 |
| Compounds Useful As Raf Kinase Inhibitors App 20150080568 - Chen; Weirong ; et al. | 2015-03-19 |
| Compounds useful as Raf kinase inhibitors Grant 8,802,657 - Cossrow , et al. August 12, 2 | 2014-08-12 |
| Compounds Useful As Raf Kinase Inhibitors App 20130065858 - Chen; Weirong ; et al. | 2013-03-14 |
| Compounds useful as Raf kinase inhibitors Grant 8,293,752 - Chen , et al. October 23, 2 | 2012-10-23 |
| Heteroaryl Compounds Useful As Raf Kinase Inhibitors App 20120040951 - Chuaqui; Claudio ; et al. | 2012-02-16 |
| Heterocyclic compounds useful as RAF kinase inhibitors Grant 7,968,536 - Cossrow , et al. June 28, 2 | 2011-06-28 |
| A.sub.2a adenosine receptor antagonists Grant 7,834,014 - Peng , et al. November 16, 2 | 2010-11-16 |
| Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment Grant 7,763,620 - Hamilton , et al. July 27, 2 | 2010-07-27 |
| Triazolopyrazines and methods of making and using the same Grant 7,674,791 - Dowling , et al. March 9, 2 | 2010-03-09 |
| Compounds Useful As Raf Kinase Inhibitors App 20090036419 - Chen; Weirong ; et al. | 2009-02-05 |
| Heterocyclic Compounds Useful as RAF Kinase Inhibitors App 20090005359 - Cossrow; Jennifer ; et al. | 2009-01-01 |
| Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and Methods of Treatment App 20080221123 - Hamilton; Andrew D. ; et al. | 2008-09-11 |
| A2a adenosine receptor antagonists App 20070173505 - Peng; Hairuo ; et al. | 2007-07-26 |
| Triazolopyrazines and methods of making and using the same App 20070010520 - Dowling; JamesE ; et al. | 2007-01-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 